These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19195735)

  • 1. Nicotine replacement therapy practices in Finland one year after deregulation of the product sales--has anything changed from the community pharmacy perspective?
    Kurko T; Linden K; Vasama M; Pietilä K; Airaksinen M
    Health Policy; 2009 Aug; 91(3):277-85. PubMed ID: 19195735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of deregulation on the prices of nicotine replacement therapy products in Finland.
    Aalto-Setälä V; Alaranta A
    Health Policy; 2008 May; 86(2-3):355-62. PubMed ID: 18207603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and acquisition of nicotine replacement therapy products among underaged adolescents after deregulation of the sales.
    Rainio SU; Huhtala HS; Rimpelä AH
    Nicotine Tob Res; 2010 Aug; 12(8):870-3. PubMed ID: 20622024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
    Paul CL; Tzelepis F; Walsh RA; Turner R
    Drug Alcohol Rev; 2007 Jul; 26(4):429-33. PubMed ID: 17564880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacists' involvement in smoking cessation: familiarity and implementation of the National smoking cessation guideline in Finland.
    Kurko T; Linden K; Pietilä K; Sandström P; Airaksinen M
    BMC Public Health; 2010 Jul; 10():444. PubMed ID: 20670409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy placement of nonprescription nicotine replacement therapy products and community pharmacists' counseling for product use.
    Kilfoy BA; Prokhorov AV; Hudmon KS
    J Am Pharm Assoc (2003); 2006; 46(6):723-8. PubMed ID: 17176688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing trends for nicotine replacement therapy in primary care.
    Tilson L; Bennett K; Barry M
    Ir Med J; 2004 Oct; 97(9):270-3. PubMed ID: 15568584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescents' self-reported reasons for using nicotine replacement therapy products: a population-based study.
    Raisamo SU; Doku DT; Rimpelä AH
    Addict Behav; 2011 Sep; 36(9):945-7. PubMed ID: 21636216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do pharmacy staff recommend evidenced-based smoking cessation products? A pseudo patron study.
    Chiang PP; Chapman S
    J Clin Pharm Ther; 2006 Jun; 31(3):205-9. PubMed ID: 16789985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacists' counseling regarding nicotine replacement therapy: A secret shopper study.
    Sokol M; Do A; Hui D; St Jacques S; Sureshbabu S; Weerakoon-Wijeratne A; Bhakta K; Humpert S; Witry M; Evoy KE
    J Am Pharm Assoc (2003); 2023; 63(2):574-581.e3. PubMed ID: 36549932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities and perceptions of pharmacists providing tobacco control services in community pharmacy in Thailand.
    Thananithisak C; Nimpitakpong P; Chaiyakunapruk N
    Nicotine Tob Res; 2008 May; 10(5):921-5. PubMed ID: 18569768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacists' role in smoking cessation activities in Alsace].
    Le Louarn A; Gérard S
    Sante Publique; 2002 Jun; 14(2):121-34. PubMed ID: 12375518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' readiness to assess consumers' over-the-counter product selections.
    Taylor J; Berger B; Anderson-Harper H; Grimley D
    J Am Pharm Assoc (Wash); 2000; 40(4):487-94. PubMed ID: 10932457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing patient care in community pharmacies: practice and research in Finland.
    Bell JS; Väänänen M; Ovaskainen H; Närhi U; Airaksinen MS
    Ann Pharmacother; 2007 Jun; 41(6):1039-46. PubMed ID: 17504836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Email medication counseling services provided by Finnish community pharmacies.
    Pohjanoksa-Mäntylä MK; Kulovaara H; Bell JS; Enäkoski M; Airaksinen MS
    Ann Pharmacother; 2008 Dec; 42(12):1782-90. PubMed ID: 19033478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes of Finnish community pharmacists toward concordance.
    Kansanaho HM; Puumalainen II; Varunki MM; Airaksinen MS; Aslani P
    Ann Pharmacother; 2004 Nov; 38(11):1946-53. PubMed ID: 15466906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' perceptions of participation in a community pharmacy-based nicotine replacement therapy distribution program.
    Hoch MA; Hudmon KS; Lee L; Cupp R; Aragon L; Tyree RA; Corelli RL
    J Community Health; 2012 Aug; 37(4):848-54. PubMed ID: 22143162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a professional program in Finnish community pharmacies in 2000-2002.
    Kansanaho H; Puumalainen I; Varunki M; Ahonen R; Airaksinen M
    Patient Educ Couns; 2005 Jun; 57(3):272-9. PubMed ID: 15893208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' knowledge of COPD, and practices and perceptions of medication counseling of COPD patients.
    Heikkilä JM; Parkkamäki S; Salimäki J; Westermarck S; Pohjanoksa-Mäntylä M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2065-2074. PubMed ID: 30013334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.